Evidence map›Paper›PMID 33901103›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2021

Using Novel Approaches to Evaluate Behavioral Interventions: Overlooked Significant HIV Prevention Effects in the HPTN 015 Project EXPLORE.

Eileen V Pitpitan, David P MacKinnon, Lisa A Eaton, Laramie R Smith, Jennifer Wagman, Thomas L Patterson

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Eileen V PitpitanSchool of Social Work, San Diego State University, San Diego, CA.
David P MacKinnonDepartment of Psychology, Arizona State University, Tempe, AZ.
Lisa A EatonDepartment of Human, Development and Family Sciences, University of Connecticut, Storrs, CT; and.
Laramie R SmithDepartments of Medicine, and Psychiatry University of California San Diego, San Diego, CA.
Jennifer WagmanFielding School of Public Health, University of California Los Angeles, Los Angeles, CA.
Thomas L PattersonDepartments of Medicine, and Psychiatry University of California San Diego, San Diego, CA.
University of California, San Diego · USArizona State University · USSan Diego State University · USUniversity of California, Los Angeles · USUniversity of Connecticut · US

Funding

Estimating Mediation Effects in Prevention StudiesR37DA009757 · NIDA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI MACKINNON, DAVID P · 2015 to 2024
$3.5M
Estimating Mediation and Moderation Effects in HIV Incidence Prevention TrialsR01DA042666 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PITPITAN, EILEEN VIRTUSIO · 2018 to 2022
$2.6M
HIV Treatment and Substance Use in LMIC Shaping MSMs Sociostructural ContextK01DA039767 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SMITH, LARAMIE RAE · 2015 to 2019
$906k
NIDA NIH HHS K01 DA039767NIDA NIH HHS R01 DA042666NIDA NIH HHS R37 DA009757
6 · The paper itself

Abstract

backgroundMediated and moderated processes that lead to intervention efficacy may underlie results of trials ruled as nonefficacious. The overall purpose of this study was to examine such processes to explain the findings of one of the largest, rigorously conducted behavioral intervention randomized controlled trials, EXPLORE.

methodsFour thousand two hundred ninety-five HIV-negative men who have sex with men (MSM) in the United States were randomized in a 2-armed trial. Participants completed follow-up and an HIV test every 6 months up to 48 months. We used multiple and causal mediation analyses to test 5 mediators, including safer sex self-efficacy and condomless receptive anal sex with HIV-positive or status-unknown partners on our primary outcome (HIV seroconversion). We also examined whether intervention effects on the mediators would be moderated by robust correlates of HIV among MSM, including stimulant use.

resultsThere were significant effects of the intervention on all hypothesized mediators. Stimulant use moderated the effect on condomless receptive anal sex In stratified multiple mediation models, we found that among MSM with low stimulant use, the intervention significantly prevented HIV by reducing condomless receptive anal sex with HIV-positive or status-unknown partners. Among MSM with higher stimulant use, there were no indirect effects of the intervention on HIV through any of the hypothesized mediators.

conclusionThe results suggest that the null effect found in the original EXPLORE trial might have occurred as a function of previously unexplored mediated and moderated processes. This study illustrates the value of testing mediated and moderated pathways in randomized trials, even in trials ruled out as nonefficacious.

Indexed as

Behavior TherapyCentral Nervous System StimulantsHIV InfectionsHomosexuality, MaleHumansMaleRisk-TakingSexual PartnersSubstance-Related DisordersUnited StatesUnsafe SexCentral Nervous System Stimulants

Identifiers

PMID33901103
PMCPMC8496973
OpenAlexW3159872795

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.